DK138691B - Analogifremgangsmåde til fremstilling af imidazo(5,1-f)triazinoner eller salte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af imidazo(5,1-f)triazinoner eller salte deraf.

Info

Publication number
DK138691B
DK138691B DK525172AA DK525172A DK138691B DK 138691 B DK138691 B DK 138691B DK 525172A A DK525172A A DK 525172AA DK 525172 A DK525172 A DK 525172A DK 138691 B DK138691 B DK 138691B
Authority
DK
Denmark
Prior art keywords
triazinones
imidazo
salts
preparation
analogous process
Prior art date
Application number
DK525172AA
Other languages
Danish (da)
English (en)
Other versions
DK138691C (bg
Inventor
Susan Constance Garside
David Hartley
Lawrence Henry Charles Lunts
Alexander William Oxford
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of DK138691B publication Critical patent/DK138691B/da
Application granted granted Critical
Publication of DK138691C publication Critical patent/DK138691C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK525172AA 1971-11-19 1972-10-23 Analogifremgangsmåde til fremstilling af imidazo(5,1-f)triazinoner eller salte deraf. DK138691B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5375071A GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions

Publications (2)

Publication Number Publication Date
DK138691B true DK138691B (da) 1978-10-16
DK138691C DK138691C (bg) 1979-03-26

Family

ID=10468856

Family Applications (1)

Application Number Title Priority Date Filing Date
DK525172AA DK138691B (da) 1971-11-19 1972-10-23 Analogifremgangsmåde til fremstilling af imidazo(5,1-f)triazinoner eller salte deraf.

Country Status (18)

Country Link
US (1) US3840537A (bg)
JP (1) JPS563873B2 (bg)
AT (1) AT321923B (bg)
AU (1) AU472127B2 (bg)
BE (1) BE791025A (bg)
CA (1) CA990292A (bg)
CH (1) CH594671A5 (bg)
DE (1) DE2255172A1 (bg)
DK (1) DK138691B (bg)
ES (1) ES408736A1 (bg)
FR (1) FR2160407B1 (bg)
GB (1) GB1400999A (bg)
IE (1) IE37046B1 (bg)
IL (1) IL40686A (bg)
NL (1) NL7215646A (bg)
PH (1) PH9669A (bg)
SE (1) SE402915B (bg)
ZA (1) ZA727532B (bg)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457873A (en) * 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DE2314488C3 (de) * 1973-03-23 1979-01-04 C.H. Boehringer Sohn, 6507 Ingelheim 8-(2,6-Dichlorphenyl)-7-(4-chlorphenyl)-5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazin, Verfahren zu dessen Herstellung und dieses enthaltene Arzneimittel
DE2335193A1 (de) * 1973-07-11 1975-01-30 Hoechst Ag Bis-triazinobenzimidazole und ihre herstellung
USRE30511E (en) * 1977-02-03 1981-02-10 American Cyanamid Company Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
US4107307A (en) * 1977-02-03 1978-08-15 American Cyanamid Company Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
US4115572A (en) * 1977-02-03 1978-09-19 American Cyanamid Company Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
US4107308A (en) * 1977-10-18 1978-08-15 American Cyanamid Company Imidazo[1,5-d]-as-triazines
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
HU187474B (en) * 1981-11-18 1986-01-28 Gyogyszerkutato Intezet,Hu Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives
US4395547A (en) * 1982-02-10 1983-07-26 American Cyanamid Co. Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
UA46166C2 (uk) * 1997-11-12 2002-05-15 Баєр Акцієнгезельшафт 2-фенілзаміщені імідазотриазинони як інгібітори фосфодіестерази, спосіб їх одержання та лікарський засіб на їх основі
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
MY126544A (en) 1998-08-26 2006-10-31 Smithkline Beecham Corp Therapies for treating pulmonary diseases
DE60043318D1 (de) * 1999-08-21 2010-01-14 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
CA2449163C (en) * 2001-05-09 2010-07-13 Bayer Healthcare Ag New use of 2-phenyl-substituted imidazotriazinones
GB0113344D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
DE10135815A1 (de) 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
EP1608656B1 (en) * 2003-04-01 2009-06-03 SmithKline Beecham Corporation Imidazotriazine compounds for the treatment of cancer diseases
DK1740591T3 (da) 2004-04-02 2009-10-26 Osi Pharm Inc Heterobicykliske proteinkinaseinhibitorer substitueret med en 6,6-biocyclisk ring
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
AU2006299232A1 (en) * 2005-09-29 2007-04-12 Bayer Schering Pharma Aktiengesellschaft PDE inhibitors and combinations thereof for the treatment of urological disorders
EP1951724B1 (en) * 2005-11-17 2011-04-27 OSI Pharmaceuticals, Inc. FUSED BICYCLIC mTOR INHIBITORS
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
MX2011011025A (es) 2009-04-20 2011-11-02 Osi Pharmaceuticals Llc Preparacion de c-piracin-metilaminas.
CN103374002B (zh) * 2012-04-19 2015-07-15 山东轩竹医药科技有限公司 磷酸二酯酶-5抑制剂
WO2016147659A1 (en) * 2015-03-16 2016-09-22 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic imidazolo derivative
WO2017000276A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
WO2017204316A1 (ja) * 2016-05-27 2017-11-30 塩野義製薬株式会社 ５－オキソ－１，２，４－トリアジン誘導体およびその医薬組成物

Also Published As

Publication number Publication date
IE37046B1 (en) 1977-04-27
FR2160407A1 (bg) 1973-06-29
IL40686A0 (en) 1972-12-29
DK138691C (bg) 1979-03-26
FR2160407B1 (bg) 1975-10-17
US3840537A (en) 1974-10-08
ES408736A1 (es) 1976-03-01
JPS4857993A (bg) 1973-08-14
AU472127B2 (en) 1976-05-20
AU4819172A (en) 1974-05-16
ZA727532B (en) 1973-07-25
SE402915B (sv) 1978-07-24
JPS563873B2 (bg) 1981-01-27
NL7215646A (bg) 1973-05-22
DE2255172A1 (de) 1973-05-24
PH9669A (en) 1976-02-10
IL40686A (en) 1975-12-31
AT321923B (de) 1975-04-25
IE37046L (en) 1973-05-19
CH594671A5 (bg) 1978-01-13
GB1400999A (en) 1975-07-16
CA990292A (en) 1976-06-01
BE791025A (fr) 1973-05-07

Similar Documents

Publication Publication Date Title
DK138691B (da) Analogifremgangsmåde til fremstilling af imidazo(5,1-f)triazinoner eller salte deraf.
DK131725B (da) Analogifremgangsmåde til fremstilling af 2,4-diaminoquinazoliner eller salte deraf.
DK134113B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-7-halogen-eller 7-trifluormethyl-6-sulfamyl-4-quinazolinoner eller salte heraf.
DK132172B (da) Analogifremgangsmåde til fremstilling af 6,7-benzomorphaner eller salte deraf.
DK138692B (da) Analogifremgangsmåde til fremstilling af s-triazolo(4,3-b)pyridaziner eller salte deraf.
DK126788B (da) Analogifremgangsmåde til fremstilling af γ-morpholino-p-amino-butyrophenoner eller salte deraf.
DK136060B (da) Analogifremgangsmåde til fremstilling af 3-substituerede 1,4,5,6-tetrahydropyridiner eller salte deraf.
DK129650B (da) Analogifremgangsmåde til fremstilling af 1-phenoxy-2-hydroxy-3-amino-propaner eller salte deraf.
DK138854B (da) Analogifremgangsmåde til fremstilling af s-triazolo(4,3-a)(1,4)benzodiazepinderivater eller 5-oxider eller salte deraf.
DK128078B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolinderivater eller salte deraf.
DK140545B (da) Analogifremgangsmåde til fremstilling af benzoylphenylsmørsyrederivater eller salte deraf.
DK138020B (da) Analogifremgangsmåde til fremstilling af pyrazolodiazepinforbindelser eller salte deraf.
DK140761B (da) Fremgangsmåde til fremstilling af indolo (2,3-a)-kinoliziner eller salte deraf.
DK135534B (da) Fremgangsmåde til fremstilling af pyrasol-(3,4-d)-pyrimidiner eller salte heraf.
DK139388B (da) Fremgangsmåde til fremstilling af 2-amino-4-hydroxy-7,7-dimethyl-7,8-dihydropteridiner eller tautomere heraf eller salte af disse forbindelser.
DK130978B (da) Analogifremgangsmåde til fremstilling af 2-methylamino-4'-methyl-4-piperazinyl-6-chlor-5-methylthiopyrimidin eller salte deraf.
DK138797B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepin-derivater eller N-oxider eller salte deraf.
DK133979B (da) Analogifremgangsmåde til fremstilling af 5-methyl-10-(beta-alkylaminethyl)-dibenzo(b,f)-azepiner eller salte deraf.
DK125025B (da) Analogifremgangsmåde til fremstilling af 2,1,3-benzothiadiazol-forbindelser eller salte deraf.
DK135504B (da) Analogifremgangsmåde til fremstilling af 6-substituerede 3-carbethoxyhydrazinopyridaziner eller salte deraf.
DK112944B (da) Fremgangsmåde til fremstilling af 7-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-cephalosporansyre eller salte deraf.
DK131374B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller salte deraf.
DK136906B (da) Analogifremgangsmåde til fremstilling af dibenzoxyrenazepinderivater eller salte deraf.
DK133622B (da) Fremgangsmåde til fremstilling af antibiotikum A28695A eller A28695B eller salte heraf.
DK139943B (da) Fremgangsmåde til fremstilling af triazolo(4,3a)(1,4)benzodiazepin-5N-oxydderivater eller syreadditionssalte deraf.